Literature DB >> 2019921

Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group.

J C Burns1, W H Mason, M P Glode, S T Shulman, M E Melish, C Meissner, J Bastian, A S Beiser, H M Meyerson, J W Newburger.   

Abstract

STUDY
OBJECTIVES: (1) To determine those diseases that most often mimic Kawasaki disease (KD) in the United States. (2) To examine the physical findings and laboratory studies that influenced experienced clinicians to exclude the diagnosis of KD. (3) To compare epidemiologic features of patients with KD and patients referred for evaluation of possible KD in whom alternative diagnoses were established.
DESIGN: Case comparison study.
SETTING: Seven pediatric tertiary care centers. PATIENTS: Consecutive sample of 280 patients with KD and 42 comparison patients examined within the first 14 days after onset of fever.
MEASUREMENTS AND MAIN RESULTS: (1) Infectious diseases, particularly measles and group A beta-hemolytic streptococcal infection, most closely mimicked KD and accounted for 35 (83%) of 42 patients in the comparison group. (2) The standard diagnostic clinical criteria for KD were fulfilled in 18 (46%) of 39 patients in whom other diagnoses were established. (3) Patients with KD were significantly less likely to have exudative conjunctivitis or pharyngitis, generalized adenopathy, and discrete intraoral lesions, and more likely to have a perineal distribution of their rash. The patients with KD were also more likely to have anemia and elevated erythrocyte sedimentation rate; leukocyte count less than 10 X 10(3)/mm3 and platelet count less than 200 X 10(3)/mm3 were significantly less prevalent in patients with KD. (4) Residence within 200 yards of a body of water was more common among KD patients.
CONCLUSIONS: (1) Measles and streptococcal infection should be excluded in patients examined for possible KD. (2) Laboratory studies that may be useful in discriminating patients with KD from those with alternative diagnoses include hemoglobin concentration, erythrocyte sedimentation rate, and serum alanine aminotransferase activity. (3) Residence near a body of water may be a risk factor for the development of KD.

Entities:  

Mesh:

Year:  1991        PMID: 2019921     DOI: 10.1016/s0022-3476(05)80026-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  36 in total

1.  Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care.

Authors:  L Appleby; G Koren; D Sharp
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

2.  Kawasaki disease--a diagnostic challenge.

Authors:  A Harnden
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

3.  Abnormal liver panel in acute kawasaki disease.

Authors:  Mohammed Eladawy; Samuel R Dominguez; Marsha S Anderson; Mary P Glodé
Journal:  Pediatr Infect Dis J       Date:  2011-02       Impact factor: 2.129

4.  Evolution of laboratory values in patients with Kawasaki disease.

Authors:  Adriana H Tremoulet; Sonia Jain; Divya Chandrasekar; Xiaoying Sun; Yuichiro Sato; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

5.  Acute severe hepatitis with coagulopathy: An unusual presentation of Kawasaki syndrome in association with Epstein-Barr virus.

Authors:  M M Gordon; E D Silverman; J H Kim; A M Huber; K Furuya
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

6.  Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease.

Authors:  Jae-Jung Kim; Sin Weon Yun; Jeong Jin Yu; Kyung Lim Yoon; Kyung-Yil Lee; Hong-Ryang Kil; Gi Beom Kim; Myung Ki Han; Min Seob Song; Hyoung Doo Lee; Jung Hye Byeon; Saejung Sohn; Young Mi Hong; Gi Young Jang; Jong-Keuk Lee
Journal:  Pediatr Cardiol       Date:  2014-09-30       Impact factor: 1.655

7.  Point-of-care differentiation of Kawasaki disease from other febrile illnesses.

Authors:  Xuefeng B Ling; John T Kanegaye; Jun Ji; Sihua Peng; Yuichiro Sato; Adriana Tremoulet; Jane C Burns; Harvey J Cohen
Journal:  J Pediatr       Date:  2012-07-20       Impact factor: 4.406

8.  Associated symptoms in the ten days before diagnosis of Kawasaki disease.

Authors:  Annette L Baker; Minmin Lu; L LuAnn Minich; Andrew M Atz; Gloria L Klein; Rosalind Korsin; Linda Lambert; Jennifer S Li; Wilbert Mason; Elizabeth Radojewski; Victoria L Vetter; Jane W Newburger
Journal:  J Pediatr       Date:  2008-11-28       Impact factor: 4.406

9.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

10.  Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection.

Authors:  Stephen J Popper; Virginia E Watson; Chisato Shimizu; John T Kanegaye; Jane C Burns; David A Relman
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.